财务摘要（报告期）（Intercept Pharmaceuticals Inc）
| 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|
| 每股指标： | |||||||
| 每股收益EPS基本(元) | -0.98 | -0.91 | -0.77 | 6.56 | 7.76 | -0.83 | -0.58 |
| 每股净资产(元) | 1.72 | 1.62 | 1.61 | 2.24 | 2.60 | -12.41 | -12.51 |
| 每股经营现金净流量(元) | -1.39 | -1.79 | -1.24 | -0.64 | -0.53 | -0.18 | -0.68 |
| 每股现金流量净额(元) | 1.14 | 1.95 | 0.17 | -0.93 | 0.62 | -0.92 | -1.18 |
| 每股营业收入(元) | 5.75 | 3.63 | 1.63 | 6.88 | 5.03 | 4.39 | 2.98 |
| 盈利能力： | |||||||
| 销售毛利率(%) | 99.75 | 99.73 | 99.67 | 99.66 | 99.54 | 99.59 | 99.14 |
| 销售净利率(%) | -16.96 | -25.05 | -47.29 | 77.64 | 116.38 | -18.95 | -19.51 |
| 净资产收益率平均(%) | -49.46 | -47.31 | -40.10 | -488.12 | -636.14 | 8.96 | 6.22 |
| 总资产净利率(%) | -8.62 | -7.32 | -6.08 | 41.05 | 44.67 | -4.84 | -3.35 |
| 投入资本回报率ROIC(%) | -10.28 | -8.92 | -6.79 | 46.92 | 54.62 | -5.62 | -3.85 |
| 收益质量： | |||||||
| 营业利润／利润总额(%) | 107.17 | 102.77 | 99.22 | 39.01 | 31.82 | 74.55 | 59.43 |
| 经营活动产生的现金流量净额／营业收入(%) | -24.21 | -49.38 | -75.92 | -9.37 | -10.54 | -4.11 | -22.72 |
| 资本结构： | |||||||
| 资产负债率(%) | 81.73 | 86.06 | 86.67 | 83.19 | 80.75 | 174.17 | 173.86 |
| 权益乘数 | 5.47 | 7.17 | 7.50 | 5.95 | 5.20 | -1.35 | -1.35 |
| 产权比率 | 4.47 | 6.17 | 6.50 | 4.95 | 4.20 | -2.35 | -2.35 |
| 流动资产／总资产(%) | 97.53 | 97.14 | 97.30 | 97.55 | 97.49 | 97.68 | 94.83 |
| 非流动资产／总资产(%) | 2.47 | 2.86 | 2.70 | 2.45 | 2.51 | 2.32 | 5.17 |
| 流动负债／负债合计(%) | 28.27 | 44.84 | 47.41 | 49.95 | 49.05 | 17.44 | 17.26 |
| 非流动负债／负债合计(%) | 71.73 | 55.16 | 52.59 | 50.05 | 50.95 | 82.56 | 82.74 |
| 归属母公司股东的权益／投入资本(%) | 24.74 | 19.39 | 15.18 | 18.50 | 24.13 | -83.94 | -81.70 |
| 偿债能力： | |||||||
| 流动比率 | 4.22 | 2.52 | 2.37 | 2.35 | 2.46 | 3.22 | 3.16 |
| 速动比率 | 4.22 | 2.52 | 2.37 | 2.35 | 2.46 | 3.22 | 3.16 |
| 货币资金／流动负债(%) | 113.09 | 72.84 | 29.65 | 21.96 | 51.08 | 38.31 | 31.99 |
| 营业利润／流动负债(%) | -47.74 | -20.72 | -15.27 | -29.65 | -22.67 | -26.47 | -6.80 |
| 经营活动产生的现金流量净额／流动负债(%) | -64.08 | -40.05 | -24.91 | -11.64 | -9.92 | -3.56 | -13.32 |
| 归属母公司股东的权益／负债合计(%) | 22.36 | 16.19 | 15.38 | 20.21 | 23.84 | -42.59 | -42.48 |
| 经营活动产生的现金流量净额／负债合计(%) | -18.12 | -17.96 | -11.81 | -5.81 | -4.86 | -0.62 | -2.30 |
| 营业利润／负债合计(%) | -13.50 | -9.29 | -7.24 | -14.81 | -11.12 | -4.62 | -1.17 |
| 成长能力： | |||||||
| 总资产同比增长率(%) | -29.72 | -2.80 | 0.14 | 5.06 | 6.95 | -4.71 | -3.22 |
| 每股净资产同比增长率(%) | -33.91 | 113.03 | 112.88 | 136.03 | 149.23 | -102.80 | -107.44 |
| 总负债同比增长率(%) | -28.87 | -51.97 | -50.08 | -35.21 | -33.48 | 19.55 | 21.53 |
| 基本每股收益同比增长率(%) | -112.63 | -9.64 | -32.76 | 328.57 | 559.17 | 46.45 | 52.46 |
| 归属母公司股东的权益同比增长率(%) | -33.28 | 118.26 | 118.07 | 150.60 | 169.01 | -82.01 | -85.88 |
| 营业利润同比增长率(%) | 13.66 | 3.33 | -19.69 | 32.06 | 29.86 | 22.98 | 65.00 |
| 营业收入同比增长率(%) | 15.34 | 15.87 | 14.90 | 9.57 | 8.52 | 4.32 | 8.48 |
| 股东权益合计同比增长率(%) | -33.28 | 118.26 | 118.07 | 150.60 | 169.01 | -82.01 | -85.88 |
| 营运能力： | |||||||
| 流动资产周转率次(次) | 0.52 | 0.30 | 0.13 | 0.55 | 0.40 | 0.26 | 0.18 |
| 固定资产周转率次(次) | 265.85 | 160.25 | 72.07 | 130.94 | 89.62 | 59.79 | 27.53 |
| 总资产周转率次(次) | 0.51 | 0.29 | 0.13 | 0.53 | 0.38 | 0.26 | 0.17 |
| 衍生指标： | |||||||
| 现金及现金等价物净增加额TTM(元) | -16,520,000.00 | 70,355,000.00 | 3,551,000.00 | -38,549,000.00 | 43,211,000.00 | -86,671,000.00 | -40,906,000.00 |
| 利润总额TTM(元) | -57,467,000.00 | -158,794,000.00 | -173,304,000.00 | -174,858,000.00 | -157,465,000.00 | -70,319,000.00 | -68,290,000.00 |
| 毛利TTM(元) | 317,052,000.00 | 305,624,000.00 | 293,539,000.00 | 284,726,000.00 | 376,557,000.00 | 365,809,000.00 | 367,341,000.00 |
| 投入资本(元) | 290,426,000.00 | 348,406,000.00 | 442,681,000.00 | 503,194,000.00 | 446,209,000.00 | 440,578,000.00 | 455,037,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -63,019,000.00 | -96,293,000.00 | -58,253,000.00 | -26,780,000.00 | -17,372,000.00 | 2,778,000.00 | -7,113,000.00 |
| 总营业收入TTM(元) | 317,684,000.00 | 306,483,000.00 | 294,522,000.00 | 285,710,000.00 | 379,842,000.00 | 368,894,000.00 | 370,389,000.00 |
| 归属母公司净利润TTM(元) | -61,612,000.00 | 208,631,000.00 | 206,965,000.00 | 221,816,000.00 | 206,361,000.00 | -64,724,000.00 | -68,290,000.00 |